← Eichor
Study identifier: NCT07419633 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.

Condition: Muscle · Cognitive Functioning · Geriatric  ·  Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

PhaseNA
Planned participants120
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersYes

About this study

In this study, participants will be assigned to receive HMB, 2-HOBA, a combination of both, or a comparison supplement for a set period of time. During the study, participants will attend scheduled visits where researchers will assess muscle strength, physical function, and overall health. Blood samples may be collected to measure markers related to metabolism, inflammation, and oxidative stress. Study staff will also monitor safety and any side effects throughout the study.

This description comes directly from the study's public registry record.

Talk to the study team

Sharmila Program manager  ·  514-984-9975  ·  reachlab@muhc.mcgill.ca

Guy Hajj Boutros, PhD  ·  514-501-9975  ·  guyelhajj@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

RI-MUHCMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07419633